2nd Department of Cardiology, Attikon University Hospital, National and Kapodistrian University of Athens Medical School, 12462, Athens, Greece.
Department of Occupational Therapy, University of Western Macedonia, 50200, Ptolemaida, Greece.
Heart Fail Rev. 2023 Jul;28(4):781-793. doi: 10.1007/s10741-022-10272-4. Epub 2022 Sep 20.
Heart failure (HF) is a global public health burden, characterized by frequent emergency department (ED) visits and hospitalizations. Identifying successful strategies to avoid admissions is crucial for the management of acutely decompensated HF, let alone resource utilization. The primary challenge for ED management of patients with acute heart failure (AHF) lies in the identification of those who can be safely discharged home instead of being admitted. This is an elaborate decision, based on limited objective evidence. Thus far, current biomarkers and risk stratification tools have had little impact on ED disposition decision-making. A reliable definition of a low-risk patient profile is warranted in order to accurately identify patients who could be appropriate for early discharge. A brief period of observation can facilitate risk stratification and allow for close monitoring, aggressive treatment, continuous assessment of response to initial therapy and patient education. Lung ultrasound may represent a valid bedside tool to monitor cardiogenic pulmonary oedema and determine the extent of achieved cardiac unloading after treatment in the observation unit setting. Safe discharge mandates multidisciplinary collaboration and thoughtful assessment of socioeconomic and behavioural factors, along with a clear post-discharge plan put forward and a close follow-up in an outpatient setting. Ongoing research to improve ED risk stratification and disposition of AHF patients may mitigate the tremendous public health challenge imposed by the HF epidemic.
心力衰竭(HF)是全球公共卫生负担,其特征是频繁到急诊部(ED)就诊和住院。确定避免住院的成功策略对于急性失代偿性 HF 的管理至关重要,更不用说资源利用了。ED 管理急性心力衰竭(AHF)患者的主要挑战在于识别那些可以安全出院而不是入院的患者。这是一个基于有限客观证据的精心决策。迄今为止,目前的生物标志物和风险分层工具对 ED 处置决策的影响甚微。需要有一个可靠的低危患者特征定义,以便准确识别适合早期出院的患者。短暂的观察期可以促进风险分层,并允许密切监测、积极治疗、持续评估对初始治疗的反应和患者教育。肺部超声可能是一种有效的床边工具,可以监测心源性肺水肿,并在观察单元环境中确定治疗后心脏卸载的程度。安全出院需要多学科合作,并对社会经济和行为因素进行深思熟虑的评估,同时提出明确的出院后计划,并在门诊环境中进行密切随访。正在进行的研究旨在改善 ED 风险分层和 AHF 患者的处置,这可能会减轻 HF 流行带来的巨大公共卫生挑战。